H3 Biomedicine Inc., a start-up focused on cancer treatments based on genetics, officially unveiled its new office in Cambridge yesterday. Todd R. Golub, HMS professor of pediatrics at the Dana-Farber Cancer Institute, is one of the scientific founders of the company.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?